title: [Cytostatic hyperthermic isolated limb perfusion (HILP) in VFN (General Faculty Hospital in Prague)].
abstract: Hyperthermic isolated limb perfusion (HILP) is a standardized method of treatment in selected patients with in-transient locoregional recurrence/methastasis of melanoma or, some other soft tissue tumors (incl. sarcoma etc.) Authors present history and current status of this treatment modality in General University Hospital in Prague. During one year period (7/2009-6/2010) 10 patients were indicated for this procedure. We performed 13 procedures (3x redo), 11 in lower extremity and 2 in upper extremity. There was no serious complication in this cohort of patiens. Multidisciplinar approach is indicated in melanoma patients care.
authors.affiliation: II. Chirurgická klinika, kardiovaskulární chirurgie, 1. LF UK a VFN v Praze. mirekspacek@seznam.cz
authors.forename: M
authors.initials: M
authors.lastname: Spacek
authors.forename: P
authors.initials: P
authors.lastname: Mitás
authors.forename: L
authors.initials: L
authors.lastname: Lacina
authors.forename: I
authors.initials: I
authors.lastname: Krajsová
authors.forename: G
authors.initials: G
authors.lastname: Hodková
authors.forename: M
authors.initials: M
authors.lastname: Salmay
authors.forename: R
authors.initials: R
authors.lastname: Spunda
authors.forename: L
authors.initials: L
authors.lastname: Brlicová
authors.forename: J
authors.initials: J
authors.lastname: Lindner
mesh_terms: D010478:Chemotherapy, Cancer, Regional Perfusion; D005121:Extremities; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
chemical_list: D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan